A biopharmaceutical company with three proprietary products on the market and a R&D of drug & diagnostic products in development for the treatment of enlarged prostate, Alzheimer's disease contamination of food and drink products and bacterial infections.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
Nymox has intellectual patented technology worldwide with statin gene marker for alzheimers disease.
Their drug for shrinking prostate gland that has enlarged has no known high risk side effects. Their research on eliminating the ecoli bacteria in food is moving forward . I bleive this company is positioned for solid growth thru revenues and earnings generated by these proprietory techniques and the royalties generated by these products :leased: to other major pharmaceutical companies should enhance earnings and price..